Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

LIFESHARE BLOOD CENTER

UEI: PNAEF6YNHFY4CAGE: 40967

LIFESHARE BLOOD CENTER is a federal contractor, registered under UEI PNAEF6YNHFY4 and CAGE code 40967. It has been awarded $14,749,965 in federal contracts. Primary work spans Blood and Organ Banks, Unknown NAICS, and Biological Product (except Diagnostic) Manufacturing. Top awarding agencies include Department Of Veterans Affairs, Department Of Health And Human Services (hhs), and Department Of Homeland Security (dhs).

Contact Information

Registration and classification details

Registration

UEI Code

PNAEF6YNHFY4

CAGE Code

40967

Entity Structure

Corporate Entity (Tax Exempt)

Established

N/A

Business Classifications

Non-Profit Organization

NAICS Codes

621991Blood and Organ Banks(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

LifeShare Blood Center specializes in the collection, processing, storage, and distribution of human blood and blood-derived biological products for critical medical applications. Their core capabilities encompass the end-to-end management of blood banking operations, including plasma fractionation,...

LifeShare Blood Center specializes in the collection, processing, storage, and distribution of human blood and blood-derived biological products for critical medical applications. Their core capabilities encompass the end-to-end management of blood banking operations, including plasma fractionation, red blood cell and platelet inventory control, pathogen reduction technologies, and cold chain logistics compliant with AABB and FDA standards. The contractor delivers highly regulated biological products under strict quality assurance protocols, ensuring sterility, viability, and traceability from donor to patient. Their technical expertise includes aseptic processing, cryopreservation, and the manufacturing of therapeutic blood components tailored for transfusion medicine, with deep experience in meeting the complex demands of trauma, surgical, and chronic care settings. The contractor maintains a consistent, long-standing relationship with the Department of Veterans Affairs, providing essential blood products and associated services to VA medical centers nationwide. Their work supports the VA’s mission to sustain readiness and patient care through reliable, just-in-time delivery of life-sustaining biological materials under stringent federal healthcare protocols. LifeShare operates primarily under NAICS 621991 (Blood and Organ Banks), reflecting its role as a nonprofit blood services provider, and secondarily under 325414 (Biological Product Manufacturing), indicating its capacity to produce and distribute classified biological therapeutics beyond simple donation processing. This dual focus positions them as a hybrid entity bridging community blood banking with regulated biological manufacturing. As a Louisiana-based nonprofit organization structured as an 8H entity, LifeShare Blood Center is federally recognized for its mission-driven operations. Though not certified under federal small business programs, its operational model aligns with government requirements for biological supply chain integrity, and it maintains a regional footprint with national reach through its service agreements with federal healthcare systems.

Key Performance Metrics

Awards Count

173

All time

Active

2

Currently performing

Completed

171

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Export
621991 - Blood and Organ Banks$13.4M91.1%
- Unknown NAICS$716.3K4.9%
325414 - Biological Product (except Diagnostic) Manufacturing$552.9K3.8%
Others - Other NAICS codes (2 codes, <0.5% each)$47.3K0.3%
Awards by Agency Over Time
Awards by Place of Performance

Compete with LIFESHARE BLOOD CENTER

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for LIFESHARE BLOOD CENTER

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in LIFESHARE BLOOD CENTER's top NAICS codes and agencies

NAICS: 325414
New
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposal issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an unrestricted, IDIQ contract focused on Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC). The scope of work includes the purchase and storage of VAC, the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract features a ceiling price of 800 million dollars and a long-term performance horizon, consisting of five one-year ordering periods for VAC and direct purchases starting December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The contractor is required to produce VAC with a minimum capacity of 1.0 million doses and maintain storage on their premises under strict quality control and temperature monitoring standards. Due to the nature of the material, live FMDV is classified as a Tier 1 Select Agent, requiring specific authorization from the CDC/APHIS and adherence to rigorous shipping and security restrictions. Award will be based on the most advantageous offer, evaluating technical capability, past performance, and price, with technical and past performance factors weighted equally. Proposals must be submitted electronically in four separate volumes by November 10, 2026.
Mrpbs Minneapolis Mn

POSTED

3 days ago

DEADLINE

in 12 days
View Details
NAICS: 541611
Federal
University Centers for Excellence in Developmental Disabilities Education, Research and Service Community Impact and Capacity Building Initiative: Technical Assistance to Strengthen Outcomes for People with I/DD and Their Families
Solicitation # UCEDD
The Department of Health and Human Services, through the Administration for Community Living and the Administration on Disabilities, has issued a Request for Information to conduct market research for a contract providing network-wide training, technical assistance, and capacity-building support to University Centers for Excellence in Developmental Disabilities Education, Research and Service. The primary objective is to strengthen outcomes for people with intellectual and developmental disabilities and their families in accordance with the Developmental Disabilities Assistance and Bill of Rights Act of 2000. The contemplated scope includes the development of Community Impact Blueprints to scale promising approaches, the creation of a Strategic TA Plan to establish annual levels of effort, and the implementation of technology solutions such as a Core Functions Dashboard and an AI-assisted chatbot. The government is seeking industry feedback on the feasibility of the draft Performance Work Statement, recommended staffing models, and rough order of magnitude cost estimates. Preliminary classification is under NAICS 541611 for Administrative Management and General Management Consulting Services. The anticipated contract structure consists of a base year and four option years, requiring strict adherence to HHS Information Security Program standards and Section 508 accessibility requirements. Interested respondents must submit their capabilities and recommendations by November 3, 2026.
Department Of Health And Human Services

POSTED

8 days ago

DEADLINE

in 5 days
View Details
NAICS: 621991
Federal
Human Cadaver - Based Medical Training and Program Support Services for the 44th Medical Brigade stationed at Fort Bragg Army Base, North Carolina.
Solicitation # 0012468284
The Medical Acquisition Support Office – Alpha is seeking capable vendors to provide human cadaver-based medical training and program support for the 44th Medical Brigade. The scope of work includes the procurement and delivery of up to 20 ethically sourced, non-dissected perfused whole-body cadaver specimens annually, which must be serologically negative for HIV, Hepatitis B/C, and Syphilis. The contractor is responsible for providing refrigerated transportation to primary performance sites at Fort Bragg, NC; Fort Campbell, KY; Fort Stewart-Hunter Army Airfield, GA; and Fort Polk, LA. Additionally, the contractor must provide rental medical equipment and consumable Class VIII supplies, such as surgical packs, tourniquets, and simulated blood. The requirement includes providing highly qualified Subject Matter Experts (SMEs) to support up to 10 training events per fiscal year. These SMEs must be board-certified general surgeons with specific competencies in various trauma procedures, such as cricothyroidotomy and exploratory laparotomy, to serve as instructors and mentors. The anticipated contract structure consists of a base period followed by four one-year option periods. All personnel must comply with strict Installation Access Control System requirements, including Anti-Terrorism Level I and iWatch training, to gain access to military installations.
W40M MRC0 West

POSTED

11 days ago

DEADLINE

in about 19 hours
View Details
NAICS: 621991
Federal
6505--Human Blood and Blood Products
Solicitation # 36C25727Q0049
The Department of Veterans Affairs, Network Contracting Office 17, intends to award a single-award, firm-fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the South Texas Blood and Tissue Center. This procurement is for the supply and delivery of human blood and blood products, as well as guidance in clinical pathology procedures, to support the Audie L. Murphy Veterans Health Care Center within the South Texas Veterans Health Care System in San Antonio, Texas. The government is pursuing this as a sole source procurement under the authority of 41 U.S.C. 3304(a)(1) and FAR 6.103-1, asserting that only one responsible source can satisfy the agency's requirements. The contractor must maintain AABB and College of American Pathologists (CAP) accreditation and hold an unrevoked U.S. license from the FDA Bureau of Biologics. Key operational requirements include 24/7/365 availability and a tiered delivery system: STAT orders must be delivered within 60 minutes, ASAP orders within 2 hours, and routine orders within 24 hours. All products must be collected via closed systems under aseptic conditions, labeled according to the ABO Blood Group System and Rh type, and transported in compliance with FDA, AABB, and DOT regulations to ensure proper temperature maintenance. Acceptance of deliveries is based on STVHCS Blood Bank criteria, including physical appearance, contamination checks, and specific shelf-life minimums for red blood cells, plasma, and cryoprecipitate.
257-NETWORK Contract Office 17 (36C257)

POSTED

15 days ago

DEADLINE

in 7 days
View Details
NAICS: 621991
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute (NCI) has issued a Limited Competition Notice of Funding Opportunity (RFA-CA-28-004) to support the continuation of two critical biospecimen banking resources: the National Clinical Trials Network (NCTN) Biobanks and the Early-Phase and Experimental Clinical Trials (EET) Biobank. The primary objective is to maintain these national resources for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens. These resources facilitate translational cancer research, biomarker development, and validation by providing essential specimens from NCI-funded clinical trials. The NCI intends to fund approximately six awards for fiscal year 2027, with a total estimated funding of 19 million dollars and a maximum budget of 3 million dollars in direct costs per year for a requested project period of six years. Applications will be evaluated through the NIH peer-review system based on scientific and technical merit, significance, and the adequacy of the institutional environment. Key requirements for applicants include maintaining active registrations in SAM, eRA Commons, and Grants.gov, as well as providing specific documentation regarding the current scale of operations, accomplishments, and standard operating procedures. Awardees must adhere to NCI Best Practices for Biospecimen Resources, federal human subjects regulations under 45 CFR 46, and strict cybersecurity incident reporting protocols, including notification of incidents within 48 hours of discovery. The scope of work includes managing secure informatics systems, providing specimen collection kits, and ensuring the availability of annotated biospecimens for authorized investigators.
National Institutes Of Health

POSTED

15 days ago

DEADLINE

in 3 months
View Details
NAICS: 621991
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute is issuing a limited competition Notice of Funding Opportunity, solicitation RFA-CA-28-004, to support the continuation of two critical biospecimen banking resources. These resources include the National Clinical Trials Network Biobanks, which support the NCTN and the Community Oncology Research Program, and the Early-Phase and Experimental Clinical Trials Biospecimen Bank, which supports the ETCTN and other early-phase experimental trials. The primary objective is to maintain national infrastructure for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the study of drug response and resistance. Eligible organizations must submit applications by February 12, 2027, to be considered for funding. All submissions will undergo a standard NIH peer-review process, and only meritorious applications will be selected. These banks are essential for linking biospecimens to clinical outcome data from large multi-site trials and supporting the development of novel cancer therapies through pharmacokinetic and pharmacodynamic analyses.
National Cancer Institute

POSTED

15 days ago

DEADLINE

in 3 months
View Details
NAICS: 325414
DIBBS
JAPANESE ENCEPHALIT
Solicitation # SPE2DP-26-R-0001
Solicitation SPE2DP-26-R-0001 is a sole source, firm-fixed price, indefinite delivery, indefinite quantity contract issued by the Defense Logistics Agency for the procurement of Japanese Encephalitis Virus Vaccine, Purified, Inactivated, in single-dose prefilled syringes. The contract has an eighteen month base term with estimated quantities ranging from a minimum of 277,760 to a maximum of 394,240 units. All products must be FDA approved, serialized according to the Drug Supply Chain Security Act, and manufactured in accordance with Medical Procurement Item Description Number 5. Deliveries are designated as FOB Destination to DLA Distribution Susquehanna in New Cumberland, Pennsylvania, and must be completed within 120 days after the date of order. The successful offeror must demonstrate FDA approval or provide a manufacturer commitment letter ensuring supply availability and fixed pricing for the life of the contract. Proposals must be submitted electronically via the DLA Internet Bid Board System by November 6, 2026. Strict adherence to Medical Marking Standard No. 1D is required, specifically regarding cold chain storage between 2 and 8 degrees Celsius and detailed waterproof marking for exterior containers. Contract administration, including payment requests and receiving reports, will be managed through the Wide Area Workflow system. Award will be based on the most advantageous offer considering price, FDA approval, and agreement to all solicitation terms.
Defense Logistics Agency

POSTED

23 days ago

DEADLINE

in 8 days
View Details